Zweig-DiMenna Associates’s Amgen AMGN Stock Holding History

Zweig-DiMenna Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,100	Closed	-$214K	–	103
2018 Q4	$214K	Buy	+1,100	New	+$215K	0.02%	114
2017 Q4	–	Sell	-1,600	Closed	-$298K	–	126
2017 Q3	$298K	Buy	+1,600	New	+$283K	0.03%	141
2017 Q2	–	Sell	-2,500	Closed	-$410K	–	206
2017 Q1	$410K	Buy	+2,500	New	+$415K	0.04%	124
2015 Q4	–	Sell	-1,600	Closed	-$221K	–	247
2015 Q3	$221K	Hold	1,600	–	–	0.01%	204
2015 Q2	$246K	Hold	1,600	–	–	0.01%	203
2015 Q1	$256K	Sell	1,600 -126,674	-99%	-$20M	0.01%	219
2014 Q4	$20.4M	Buy	+128,274	New	+$20M	0.88%	40
2013 Q4	–	Sell	-241,599	Closed	-$27M	–	252
2013 Q3	$27M	Buy	241,599 +124,099	+106%	+$13.5M	1.1%	23
2013 Q2	$11.6M	Buy	+117,500	New	+$12.2M	0.47%	85

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Zweig-DiMenna Associates's AMGN Position: Q1 2019 in Review

Zweig-DiMenna Associates sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,100 shares — an estimated $214K sold.

Zweig-DiMenna Associates first reported a position in AMGN in Q2 2013 and held it in 9 quarters. The position peaked at $27M in Q3 2013. 1,887 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

Zweig-DiMenna Associates reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
Zweig-DiMenna Associates sold 1,100 Amgen shares in Q1 2019, an estimated $214K.
Zweig-DiMenna Associates first reported a position in Amgen in Q2 2013 and held it in 9 quarters.
Zweig-DiMenna Associates's Amgen position peaked at $27M in Q3 2013.
1,887 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2019, filed 29 Apr 2019.